Real patient data reflects actual clinical scenarios ā Your model excels in practice
Diverse datasets include all critical populations ā Comprehensive market coverage
Streamlined collaborations take days, not months ā First-to-market advantage
Protected, non-re-identifiable data ā Clean regulatory pathway
CHAI-certified validation ā Gold standard credibility
Millions saved in development costs, now working productively on real validation
Competitive advantage as you validate and launch, while others
negotiate
Regulatory confidence because your model was tested on real-world diversity
Investor excitement about proven commercial viability
Market leadership through validated algorithmic performance

~335K encounters
78% Black/African American
25% below poverty line
Housing instability data
Heart failure readmissions from 25% -> <11%

~550K encounters
36% Black, 25% Hispanic, 25% Caucasian
~26% Medicaid patients
Top 5 cardiovascular ranking nationwide
The future belongs to the ones who make the leap before the crowd catches on
Test Where Others Can't
"While competitors argue about de-identified data quality, you'll have validated performance on populations where algorithms actually fail."
Speed that outpaces your competition
"Days to validation results while competitors spend 18+ months negotiating data access."
Investor Confidence
"885K encounters spanning 14+ years with social determinants data = The evidence base that makes investors confident and competitors envious."
The algorithm owners who validate here first will define the standard everyone else follows.
Your choice: Lead the market or watch others set the pace.